Evidence map›Paper›PMID 29323266›Full record

ArticleCell death and differentiation2018

AIF loss deregulates hematopoiesis and reveals different adaptive metabolic responses in bone marrow cells and thymocytes.

Lauriane Cabon, Audrey Bertaux, Marie-Noëlle Brunelle-Navas, Ivan Nemazanyy, Laurianne Scourzic, Laure Delavallée, Laura Vela, Mathieu Baritaud, Sandrine Bouchet, Cécile Lopez and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Fatty acid oxidation in immune function.Frontiers in immunology · 2024
    Review
  2. Article
  3. Metabolic regulation of T cell development.Frontiers in immunology · 2022
    Review
  4. Cell Biology Meets Cell Metabolism: Energy Production Is Similar in Stem Cells and in Cancer Stem Cells in Brain and Bone Marrow.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Lauriane CabonCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France.
Audrey BertauxCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France.
Marie-Noëlle Brunelle-NavasCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France.
Ivan NemazanyyUniversité Paris Descartes, Sorbonne Paris Cité, Paris, France.
Laurianne ScourzicINSERM U1170, Institut Gustave Roussy, Villejuif, France. Université Paris-Sud/Paris Saclay, Orsay, France.
Laure DelavalléeCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France.
Laura VelaCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France.
Mathieu BaritaudCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France.
Sandrine BouchetCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France.
Cécile LopezINSERM U1170, Institut Gustave Roussy, Villejuif, France. Université Paris-Sud/Paris Saclay, Orsay, France.
Vu Quang VanImmunoregulation Laboratory, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
Kevin GarbinSorbonne Universités, Université Pierre et Marie Curie, Paris, France.
Danielle ChateauSorbonne Universités, Université Pierre et Marie Curie, Paris, France.
Françoise GilardInstitute of Plant Sciences Paris-Saclay (IPS2), UMR 9213/UMR1403, CNRS, INRA, Université d'Evry, Université Paris-Diderot, Université Paris-Sud/Paris Saclay, Orsay, France.
Marika SarfatiImmunoregulation Laboratory, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
Thomas MercherINSERM U1170, Institut Gustave Roussy, Villejuif, France. Université Paris-Sud/Paris Saclay, Orsay, France.
Olivier A BernardINSERM U1170, Institut Gustave Roussy, Villejuif, France. Université Paris-Sud/Paris Saclay, Orsay, France.
Santos A SusinCell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche des Cordeliers, INSERM UMRS 1138, Paris, France. santos.susin@crc.jussieu.fr.ORCID http://orcid.org/0000-0002-3366-1628
Inserm · FRUniversité Paris-Sud · FRCentre Hospitalier de l’Université de Montréal · CADélégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial metabolism is a tightly regulated process that plays a central role throughout the lifespan of hematopoietic cells. Herein, we analyze the consequences of the mitochondrial oxidative phosphorylation (OXPHOS)/metabolism disorder associated with the cell-specific hematopoietic ablation of apoptosis-inducing factor (AIF). AIF-null (AIF

Indexed as

HematopoiesisOxidative PhosphorylationAnimalsApoptosis Inducing FactorB-LymphocytesHematopoietic Stem CellsMiceMice, KnockoutMitochondriaReactive Oxygen SpeciesThymocytesAIFM1 protein, mouseApoptosis Inducing FactorReactive Oxygen Species

Identifiers

PMID29323266
PMCPMC5943248
OpenAlexW2784251793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.